IGC Pharma (IGC) Current Leases (2023 - 2026)

IGC Pharma (IGC) has reported Current Leases for 4 consecutive years, with $9000.0 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Current Leases fell 90.43% year-over-year to $9000.0 in Q1 2026; TTM through Mar 2026 was $9000.0, a 90.43% decrease from a year earlier, with the FY2026 full-year figure at $9000.0, down 90.43% from the prior year.
• Current Leases was $9000.0 for Q1 2026 at IGC Pharma, roughly flat from $9000.0 in the prior quarter.
• Over five years, Current Leases peaked at $134000.0 in Q3 2024 and troughed at $9000.0 in Q3 2025.
• A 4-year average of $86818.2 and a median of $124000.0 in 2023 frame the typical range for Current Leases.
• Across the five-year window, Current Leases changed 0.0% in 2024 and slumped 93.28% in 2025, its largest moves.
• Over 4 years, Current Leases stood at $124000.0 in 2023, then changed by 0.0% to $124000.0 in 2024, then slumped by 92.74% to $9000.0 in 2025, then changed by 0.0% to $9000.0 in 2026.
• The last three Current Leases figures came in at $9000.0 (Q1 2026), $9000.0 (Q4 2025), and $9000.0 (Q3 2025), per Business Quant data.